Remarks: COVID-19 mortality risk factors in older people in a long-term care center Conclusions and Implications Male gender, low Barthel index, no pharmacological treatment and lymphocytopenia are independent risk factors for COVID-19 mortality in institutionalized elderly patients in long-term care nursing homes. Treatment with hydroxychloroquine and azithromycin was associated with lower mortality in these patients. FULL STORY HERE: https://www.4cmitv.com/2020/09/11/2020-sep-09-study-finds-incredible-lower-death-rate-for-covid-patients-treated-with-hydroxychloroquine/
Figure 2. Type of treatment and percentage of COVID-19 patients cured.
H+A: Hydroxychloroquine and Azithromycin.
No treatment includes Others: Beta-lactam or Quinolone antibiotics.
Figure 1. Functional capacity and percentage of COVID-19 patients cured.
Figure 3. Prognostic COVID-19 mortality score-ROC Curve for Model
This latest study (still under going peer-review) from the tiny European nation-of Andorra found COVID infected patients that received HCQ had a 46% less chance of dying compared to those that didn’t take it.
And where Azithromycin was combined with HCQ, there was an 82% less chance of death.
We are only left to speculate how many more lives could have been saved if zinc was included.
This one study in isolation doesn’t prove anything, but it adds to dozens of studies from across the world that have found HCQ reduces deaths in Covid infected patients. The weight of evidence is now overwhelming and undeniable.
Yet anti-HCQ zealots and star-struck government health bureaucrats continue to bury their heads in the sand, and refuse to admit they have made a tragic mistake by suspending doctors’ freedom to prescribe Hydroxychloroquine to save COVID patients lives.
Likewise the HCQ deniers in main stream media continue to refuse to report these latest studies, because they don’t want to look like fools for their vilification of those that studied at evidence and argued the suspensions of doctors freedom was killing people.
Craig Kelly MP [and that includes you Chris Bowen] If you’re among the policymakers or physicians participating in this charade you may want to dissociate yourself while you can credibly plead ignorance for tens of thousands of preventable deaths.’’
BACKGROUND: New Study Finds Incredible Lower Death Rate For COVID Patients Treated With Hydroxychloroquine
STUDY: COVID-19 mortality risk factors in older people in a long-term care center
ORIGINAL SOURCE: researchsquare.com
Eva Heras – Servei Andorrà Atenció Sanitària; Pablo Garibaldi – Servei Andorrà Atenció Sanitària; Maite Boix – Servei Andorrà Atenció Sanitària; Oliver Valero – Universitat Autonoma de Barcelona; Jorge Castillo – Servei Andorrà Atenció Sanitària; Yurisan Curbelo – Servei Andorrà Atenció Sanitària; Elso Gonzalez – Servei Andorrà Atenció Sanitària; Obilagilio Mendoza – Servei Andorrà Atenció Sanitària; Maria Anglada – Servei Andorrà Atenció Sanitària; Joan Carles Miralles – Servei Andorrà Atenció Sanitària; Petra Lllull – Servei Andorrà Atenció Sanitària; Ricard Llovera – Servei Andorrà Atenció Sanitària; Josep M. Pique – Servei Andorrà Atenció Sanitària
Objectives: Despite high rates of COVID-19 infection and increased related mortality have been reported among older adults admitted in long-term care facilities, a limited amount of information is available about the natural course of this pandemic and prognostic factors in this population. In the current study, we aimed to investigate the epidemiologic, demographics, clinical, or therapeutic factors that may predict the prognosis in a cohort of COVID-19 infected elderly in a nursing home.
Methods: We conducted a retrospective analysis of all COVID-19 confirmed institutionalized elderly in a nursing home transformed into a reference intermediate healthcare facility from March 15 to June 5, 2020. Epidemiological, demographic, and frailty status before infection, and clinical, laboratory, treatment, and outcome data during infection were collected. We used bivariate analysis and multivariate logistic regression to identify risk factors for mortality.
Results: The analysis comprised all 100 COVID-19 confirmed cases during the study period. The median age was 85 years; 62% were female. The case fatality rate was 20%. In the bivariate analysis, male gender, fever, respiratory symptoms, severe cognitive decline, a low Barthel index, and lymphocytopenia were significantly associated with mortality. Multivariate logistic regression analysis identified male gender, low Barthel index, no pharmacological treatment, and lymphocytopenia as independent risk factors associated with mortality.
Conclusions and Implications: Male gender, low Barthel index, no pharmacological treatment and lymphocytopenia are independent risk factors for COVID-19 mortality in institutionalized elderly patients in long-term care nursing homes. Treatment with hydroxychloroquine and azithromycin was associated with lower mortality in these patients.f9eb4403-111d-4bd2-92a5-f694c6acc353
Hashtags: #4cminewswire, #HCQ, #Hydroxychloroquine, #COVID19, #Coronavirus, #4cminews, #4CMiTV, #4CM2020SEP09,
Tags: 4cminewswire, HCQ, Hydroxychloroquine, COVID-19, Coronavirus, 4cminews, 4CMiTV, #4CM2020SEP09,
4CMINEWS SOCIAL MEDIA:
Gab AU: https://gab.com/4cminewswire/posts/104846147481841742
Dailymotion & Facebook: DEFUNCT SOCIAL MEDIA PLATFORM